Moll F. Update On Novel Supramolecular Polymer Technology To Create Endogenous Tissue With Host Collagen And Endothelium Compatible With Flowing Blood: 2-Year Clinical Results Of The aXess Graft (From Xeltis) – Presented at 2024 Veith Symposium on 21 November 2024.
Study Number
NCT05473299
www.clinicaltrials.gov

